Review of Asian experience of thermal ablation techniques and clinical practice

International Journal of Hyperthermia

Volumn 20, Issue 7, 2004, Pages 699-712

  Rhim, H ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Image guide tumour ablation; Liver neoplasm; Microwave ablation; Percutaneous ethanol ablation; Radiofrequency ablation; Thermal ablation

Indexed keywords

ALCOHOL;

ARTICLE; ASIAN; BILE DUCT OBSTRUCTION; BILOMA; BURN; CANCER PALLIATIVE THERAPY; CHEMOEMBOLIZATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAPHRAGM INJURY; HEMATOTHORAX; HEMOPERITONEUM; HUMAN; HYPERTHERMIC THERAPY; IMAGING; INTERMETHOD COMPARISON; KIDNEY INFARCTION; LASER SURGERY; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER SURGERY; LIVER TUMOR; MICROWAVE THERAPY; PHYSICIAN; PNEUMOTHORAX; RADIOFREQUENCY; STOMACH ULCER; SURVIVAL RATE; SYNCOPE; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION;

ASIA; CATHETER ABLATION; CHINA; CRYOSURGERY; HUMANS; HYPERTHERMIA, INDUCED; JAPAN; KOREA; LASERS; MICROWAVES; NEOPLASMS; SURGERY, COMPUTER-ASSISTED;

EID: 8644283709     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/0265673042000196487     Document Type: Article

References (51)

1. Dodd GD 3rd, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y, Gillams AR, Karahan OI, Rhim H. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000; 20: 9-27.
2. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol 2000; 174: 323-31.
3. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities - part I. J Vasc Int Radiat 2001; 12: 1020-32.
4. Goldberg SN, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan JP, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ. International working group on image-guided tumor ablation. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228: 335-45.
5. Vierra M. Minimally invasive surgery. Annu Rev Med 1995; 46: 147-58.
6. Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver cancer. New York: Churchill Livingstone, 1997; 13-28.
7. Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 199: 271-85.
8. Teo EK, Fock KM. Hepatocellular carcinoma: an Asian perspective. Dig Dis 2001; 19: 263-8.
9. Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Surg 1997; 173: 358-65.
10. You WC, Jin F, Devesa S, Gridley G, Schatzkin A, Yang G, Rosenberg P, Xiang YB, Hu YR, Li Q. Rapid increase in colorectal cancer rates in urban Shanghai, 1972-97, in relation to dietary changes. J Cancer Epidemiol Prev 2002; 7: 143-6.
11. Yang CX, Kuroishi T, Huang XE, Inoue M, Tajima K. Correlation between food consumption and colorectal cancer: an ecological analysis in Japan. Asian Pac J Cancer Prev 2002; 3: 77-83.
12. Martin JK, O'Connell MJ, Wieand HS, Fitzgibbons RJ Jr, Mailliard JA, Rubin J, Nagorney DM, Tschetter LK, Krook JE. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990; 125: 1022-7.
13. Nguyen MH, Keeffe EB. Screening for hepatocellular carcinoma. J Clin Gastroenterol 2002; 35: S86-91.
14. Unoura M, Kaneko S, Matsushita E, Shimoda A, Takeuchi M, Adachi H, et al. High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology 1993; 40: 305-10.
15. Larcos G, Sorokopud H, Berry G, Farrell GC. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. Am J Roentgenol 1998; 171: 433-5.
16. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224: 47-54.
17. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular arcinoma. J Vasc Interv Radiol 2002; 13: S211-21.
18. Livraghi T, Giorgio A. Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-83.
19. Shiina S. Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, Hamada E, Takahashi M, Shiratori Y, Terano A. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993; 160: 1023-8.
20. Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 2003; 237: 171-9.
21. Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 323-8.
22. Liu LX, Zhang WH, Jiang HC. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 2003; 9: 193-200.
23. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235: 466-86.
24. Ng KK, Lam CM, Poon RT, Ai V, Tso WK, Fan ST. Thermal ablative therapy for malignant liver tumors: a critical appraisal. J Gastroenterol Hepatol 2003; 18: 616-29.
25. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, Uchiyama S, Inoue K. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74: 817-25.
26. Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245-51.
27. Murakami R, Yoshimatsu S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. Am J Roentgenol 1995; 164: 1159-64.
28. Dong BW, Zhang J, Liang P, Yu XL, Su L, Yu DJ, Su L, Yu DJ, Ji XL, Yu G. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. Int J Hyperthermia 2003; 19: 119-33.
29. Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ, Huang JF. Hepatocellular carcinoma: US-guided percutancous microwave coagulation therapy. Radiology 2001; 221: 167-72.
30. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002; 62: 64-8.
31. Ishida T, Murakami T, Shibata T, Inoue Y, Takamura M, Niinobu T, Sato T, Nakamura H. Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow. J Vasc Interv Radiol 2002; 13: 185-91.
32. Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331-7.
33. Rhim H. Current survey data for thermal ablation status in Asia. Int J Hyperthermia 2004; in press.
34. Choi D, Lim HK, Kim SH, Lee WJ, Jang HJ, Lee JY, Lee JY, Paik SW, Koh KC, Lee JH. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217: 558-63.
35. Choi D, Lim HK, Kim SH, Lee WJ, Jang HJ, Kim H, Lee SJ, Lim JH. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med 2002; 21: 391-401.
36. Lim HK, Choi D, Lee WJ, Kim SH, Lee SJ, Jang HJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001; 221: 447-54.
37. Rhim H, Goldberg SN, Dodd GD 3rd, Solbiati L, Lim HK, Tonolini M, Cho OK. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics 2001; 21: S17-35.
38. Rhim H, Dodd GD 3rd. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999; 27: 221-9.
39. Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH, Lee WJ, Lim HK, Nam GJ, Han SS, Kim YH, Park CM, Kim PN, Byun JY, et al. Major complications after radiofrequency thermal ablation of hepatic tumors. Radiographics 2003; 23: 123-34.
40. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-51.
41. Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002; 13: 1225-32.
42. Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97: 1253-62.
43. Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2002; 95: 2353-60.
44. Srivastava DN, Thulkar S, Sharma S, Pandey GK, Sahni P, Julka PK, et al. Therapeutic radiological interventional procedures in hepatocellular carcinoma. Indian J Gastroenterol 2002; 21: 96-8.
45. Varshney S, Sharma S, Pamecha V, Sewkani A, Jhawar L, Narkhede V, et al. Radiofrequency tissue ablation: an early Indian experience. Indian J Gastroenterol 2003; 22: 91-3.
46. Wang TH, Huang GT, Sheu JC, Daikuzono N, Sung JL, Chen DS. Laserthermia for the treatment of small hepatocellular carcinoma: a preliminary study. J Clin Laser Med Surg 1991; 9: 195-7.
47. Zhou XD, Tang ZY, Yu YQ, Weng JM, Ma ZC, Zhang BH, Zheng YX. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases. J Cancer Res Clin Oncol 1993; 120: 100-2.
48. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000; 217: 6333-46.
49. Livraghi T. Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003; 10: 67-76.
50. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-61.
51. Goldberg SN, Kamel IR, Kruskal JB, Reynolds K, Monsky WL, Stuart KE, Ahmed M, Raptopoulos V. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol 2002; 179: 93-101.